wet age-related macular degeneration
Conditions
Interventions
investigational material(s)
Generic name etc : -
INN of investigational material :
Therapeutic category code : --- Other
Dosage and Administration for Investigational material : -
control material(s
Sponsors
Fukushima Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)65 years old or more less than 85 years old 2)Presence of cataract 3)Presence of wet AMD in the either eye 4)Presence of wet AMD in the either eye and have well response to anti-VEGF drug intravitreal injection therapy 5)Presence of wet AMD in the either eye but have refractory against anti-VEGF drug intravitreal injection therapy
Exclusion criteria
Exclusion criteria: 1)Presence of retinal disease expect wet AMD 2)History of vitreous surgery or PDT 3)Presence of active ocular infection 4)Presence of active ocular allergic disease 5)Have received intraocular operation expect vitreous surgery or PDT within 90 days prior to enrollment 6)Presence of cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Concentration of each protein in aqueous humor and serum between different 4 groups Protein level in aqueous humor and serum is compared between the groups, respectively | — |
Outcome results
None listed